Tuesday launched its new antidepressant drug Cymbalta, saying it is now available by prescription in more than half of the nation's pharmacies.
The Indianapolis-based drugmaker said it expects more than 80% of all U.S. pharmacies -- more than 44,000 stores -- to have Cymbalta on their shelves by Aug. 30.
The Food and Drug Administration approved Cymbalta on Aug. 3 for the treatment of major depression.
About 19 million Americans suffer from depression each year, according to Lilly.
Lilly also makes Prozac, perhaps the best-known treatment for depression.
Federal regulators also recently approved Lilly's antidepression drug Symbyax, which the company says is the first federally approved treatment for bipolar depression.
Many Wall Street analysts say Lilly's research pipeline has the best near-term prospects of all the big drugmakers.
Shares rose 20 cents, or 0.3%, to $64.60.